200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Other Events
Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
Announces Plan to Explore Strategic Alternatives to Align with Targeted NDA for Rare Disease Intestinal Failure
Amended material disclosure
Jaguar Health, Inc. Enters Royalty Interest Amendments with Uptown Capital
Jaguar Health Enters $40 Million Equity Line of Credit Agreement
Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders
Jaguar Health Enters Material Exchange Agreements with Streeterville Capital
Q1
Notice of Late Filing for Quarterly Report
FY 2025
Notice of Late Filing for Annual Report
Q3
Q2
Amended Annual Report
Notice of Exempt Offering of Securities
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
PRE 14A
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Submission Upload
Correspondence